Pulmonary Barotrauma in COVID-19 Patients Under Non-invasive Ventilation Support: Case Series |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.15, No. 4)Publication Date: 2022-02-14
Authors : Sérgio Renato da Rosa Decker; Matheus Wohlfahrt Baumgarten; Carina Andressa Dick; Rodrigo José de Souza Domingues;
Page : 467-472
Keywords : Pulmonary barotrauma; COVID-19; Non-invasive ventilation; Azithromycin; Hydroxychloroquine;
Abstract
Purpose: Pulmonary barotrauma (PBT) is a complication typically seen in intubated patients but is a rare event in those using non-invasive ventilation (NIV) support. In this case report, we identified five patients with COVID-19 who developed PBT on NIV support in a hospital of southern Brazil from March to April 2021.
Results: All the patients were non-smokers with no pre-existing lung disease. They required oxygen therapy which included escalation from nasal cannula to NIV. PBT was diagnosed later in the course of the disease (17.6 ± 4.3 days) and after a mean time of 6 days on NIV support.
Other Latest Articles
- Performance Improvement Project in Health Care System and Its Advantages Using Quality Management Tolls |Biomedgrid
- Mitochondrial Proteins as Molecular Targets For Glutathione-Based Drugs |Biomedgrid
- Analysis of the Mice Activity Profile in the Model of Spontaneous Aggression (MSA) |Biomedgrid
- The Challenges Facing Higher Education in Light of Corona Virus (COVID-19) and Its Impact on Student’s Academic Achievement: Empirical Study on Jordanian and Syrian Private Universities
- Evaluating the Qualitative Performance of Algerian Universities after the Implementation of Reform and Change: From the Student's View
Last modified: 2024-01-24 21:43:29